178 related articles for article (PubMed ID: 18636785)
1. Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System (VAERS).
Woo EJ; Ball R; Burwen DR; Braun MM
Drug Saf; 2008; 31(8):667-74. PubMed ID: 18636785
[TBL] [Abstract][Full Text] [Related]
2. Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
Martin D; Menschik D; Bryant-Genevier M; Ball R
Drug Saf; 2013 Jul; 36(7):547-56. PubMed ID: 23657824
[TBL] [Abstract][Full Text] [Related]
3. Comparing data mining methods on the VAERS database.
Banks D; Woo EJ; Burwen DR; Perucci P; Braun MM; Ball R
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):601-9. PubMed ID: 15954077
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
5. Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification.
Osokogu OU; Dodd C; Pacurariu A; Kaguelidou F; Weibel D; Sturkenboom MC
Drug Saf; 2016 Sep; 39(9):873-81. PubMed ID: 27255487
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients.
Baksh SN; McAdams-DeMarco M; Segal JB; Alexander GC
Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):660-667. PubMed ID: 29655237
[TBL] [Abstract][Full Text] [Related]
7. Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005-June 2013.
Haber P; Moro PL; McNeil MM; Lewis P; Woo EJ; Hughes H; Shimabukuro TT
Vaccine; 2014 Nov; 32(48):6499-504. PubMed ID: 25258101
[TBL] [Abstract][Full Text] [Related]
8. Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.
Almenoff JS; LaCroix KK; Yuen NA; Fram D; DuMouchel W
Drug Saf; 2006; 29(10):875-87. PubMed ID: 16970511
[TBL] [Abstract][Full Text] [Related]
9. Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013.
Miller ER; Moro PL; Cano M; Lewis P; Bryant-Genevier M; Shimabukuro TT
Vaccine; 2016 May; 34(25):2841-6. PubMed ID: 27087150
[TBL] [Abstract][Full Text] [Related]
10. Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions.
Hauben M; Horn S; Reich L
Drug Saf; 2007; 30(2):143-55. PubMed ID: 17253879
[TBL] [Abstract][Full Text] [Related]
11. Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles.
Bailey S; Singh A; Azadian R; Huber P; Blum M
Drug Saf; 2010 Feb; 33(2):139-46. PubMed ID: 20082540
[TBL] [Abstract][Full Text] [Related]
12. Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination.
Niu MT; Erwin DE; Braun MM
Vaccine; 2001 Sep; 19(32):4627-34. PubMed ID: 11535310
[TBL] [Abstract][Full Text] [Related]
13. Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017.
Landazabal CS; Moro PL; Lewis P; Omer SB
Vaccine; 2019 Feb; 37(9):1229-1234. PubMed ID: 30660400
[TBL] [Abstract][Full Text] [Related]
14. Impact of stratification on adverse drug reaction surveillance.
Hopstadius J; Norén GN; Bate A; Edwards IR
Drug Saf; 2008; 31(11):1035-48. PubMed ID: 18840023
[TBL] [Abstract][Full Text] [Related]
15. Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.
Moro PL; Cragan J; Lewis P; Sukumaran L
Birth Defects Res; 2017 Jul; 109(13):1057-1062. PubMed ID: 28762675
[TBL] [Abstract][Full Text] [Related]
16. A Review of the Food and Drug Administration Adverse Event Reporting System for Tramadol-Related Hypoglycemia.
Juba KM; van Manen RP; Fellows SE
Ann Pharmacother; 2020 Mar; 54(3):247-253. PubMed ID: 31648533
[No Abstract] [Full Text] [Related]
17. Vaccine-based subgroup analysis in VigiBase: effect on sensitivity in paediatric signal detection.
de Bie S; Verhamme KM; Straus SM; Stricker BH; Sturkenboom MC
Drug Saf; 2012 Apr; 35(4):335-46. PubMed ID: 22435344
[TBL] [Abstract][Full Text] [Related]
18. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
Szarfman A; Machado SG; O'Neill RT
Drug Saf; 2002; 25(6):381-92. PubMed ID: 12071774
[TBL] [Abstract][Full Text] [Related]
19. Commonality of drug-associated adverse events detected by 4 commonly used data mining algorithms.
Sakaeda T; Kadoyama K; Minami K; Okuno Y
Int J Med Sci; 2014; 11(5):461-5. PubMed ID: 24688309
[TBL] [Abstract][Full Text] [Related]
20. Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009-2017.
Suragh TA; Lewis P; Arana J; Mba-Jonas A; Li R; Stewart B; Shimabukuro TT; Cano M
Br J Clin Pharmacol; 2018 Dec; 84(12):2928-2932. PubMed ID: 30229993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
